Zhou, Diansong <br/><br/>
Evaluation of the Drug-Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP-5862, Using a Physiologically-Based Pharmacokinetic Modeling Approach.  [electronic resource] 

 -  CPT: pharmacometrics & systems pharmacology  07 2019 
 - 489-499 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2163-8306 
<br/><br/><label>Standard No.: </label>10.1002/psp4.12408  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzamides--pharmacokinetics<br/>Clinical Trials, Phase I as Topic<br/>Computer Simulation<br/>Cytochrome P-450 CYP3A Inhibitors--pharmacokinetics<br/>Drug Interactions<br/>Humans<br/>Models, Biological<br/>Pyrazines--pharmacokinetics